Safety and Efficacy of Lutikizumab (ABT-981), An Anti–Interleukin-1 Alpha/Beta Dual Variable Domain (DVD) Immunoglobulin, in Subjects with Knee Osteoarthritis: Results from the Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2 Trial

Safety and Efficacy of Lutikizumab (ABT-981), An Anti–Interleukin-1 Alpha/Beta Dual Variable Domain (DVD) Immunoglobulin, in Subjects with Knee Osteoarthritis: Results from the Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2 Trial

Read the publication >

Published:
June 20, 2018

Publication:
Annals of the Rheumatic Diseases

Authors:
R. Fleischmann, H. Bliddal, F. Blanco, T. Schnitzer, C. Peterfy, S. Chen, L. Wang, P. Conaghan, F. Berenbaum, J.-P. Pelletier, J. Martel-Pelletier, O. Vaeterlein, W. Liu, G. Levy, L. Zhang, J. Medema, M. Levesque